Darapladib Ameliorates Radiation-Induced Skin Injury and Fibrosis by Lipoprotein-Associated Phospholipase A2 Inhibition
Biomolecules · 2026
DOI: 10.3390/biom16091292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Ji-Eun Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea. Hauptthemen laut MEDLINE: Benzaldehydes, Skin, 1-Alkyl-2-acetylglycerophosphocholine Esterase, Oximes. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Korea Institute of Radiological and Medical Sciences, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Current studies have elucidated the mechanisms of radiation-induced skin injury (RISI) and identified several medical countermeasures to reduce its severity. However, no treatment has yet proven effective in preventing or reversing radiation-induced skin fibrosis. Here, we show that radiation upregulates lipoprotein-associated phospholipase A2 (Lp-PLA2) expression and induces endothelial cell dysfunction, characterized by an increased DNA damage response and reduced tube-forming capacity and mitochondrial function. To define the role of Lp-PLA2 in the progression of RISI, we treated human dermal microvascular endothelial cells and the skin of SKH1 hairless mice with darapladib, a selective Lp-PLA2 inhibitor. In endothelial cells, darapladib attenuated radiation-induced cellular damage and suppressed endothelial-to-mesenchymal transition (EndoMT). In irradiated mouse skin, darapladib reduced radiation-induced inflammation, adipose tissue disruption, dermal thickness, and skin fibrosis. Notably, darapladib modulated macrophage polarization and inhibited radiation-induced macrophage infiltration in irradiated skin. These findings suggest that Lp-PLA2 inhibition may reveal potential targets for the treatment of RISI and other fibrotic skin diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divisions of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
- School of Radiological and Medical Sciences, University of Science and Technology (UST), 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea.
ORCID-Profile: Narae Kim, Yoon-Jin Lee, Kwang Seok Kim
Förderung
- Ministry of Science and ICT
- Korea Institute of Radiological and Medical Sciences
- Ministry of Science, ICT and Future Planning
- Basic Science Research Program
Zitieren
APA
Park, J. E., Kim, N., Kim, S. R., Lee, S. H., Lee, Y. J., & Kim, K. S. (2026). Darapladib Ameliorates Radiation-Induced Skin Injury and Fibrosis by Lipoprotein-Associated Phospholipase A2 Inhibition. Biomolecules. https://doi.org/10.3390/biom16091292
Vancouver
Park JE, Kim N, Kim SR, Lee SH, Lee YJ, Kim KS. Darapladib Ameliorates Radiation-Induced Skin Injury and Fibrosis by Lipoprotein-Associated Phospholipase A2 Inhibition. Biomolecules. 2026. doi:10.3390/biom16091292
BibTeX
@article{Park2026,
author = {Park, Ji-Eun and Kim, Narae and Kim, So-Ra and Lee, Soo-Ho and Lee, Yoon-Jin and Kim, Kwang Seok},
title = {Darapladib Ameliorates Radiation-Induced Skin Injury and Fibrosis by Lipoprotein-Associated Phospholipase A2 Inhibition},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091292}
}
EUVIMED